n.a. (CHTP)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)
Insiders Trading SGEN, MSFT, CHTP

Insiders Trading SGEN, MSFT, CHTP

The top 10 open-market insider purchases and sales filed at the SEC Friday.

Chelsea Tries Spin Job on Failed Drug Trial

Chelsea Tries Spin Job on Failed Drug Trial

Chelsea insists Northera's FDA filing is on track despite two of three failed phase III studies.

Chelsea Therapeutics CEO Discusses Q3 2010 Results – Earnings Call Transcript

Chelsea Therapeutics CEO Discusses Q3 2010 Results â¿¿ Earnings Call Transcript

Chelsea Therapeutics Reports Third Quarter 2010 Results

Company to Host Conference Call at 4:30 PM ET

Green Mountain, Sealy: Volume Movers

Green Mountain Coffee Roasters and Sealy were among stocks poised to move on above-average volume Wednesday.

Chelsea, L-1 Identity: Volume Movers

Several stocks, including Chelsea Therapeutics and L-1 Identity, are poised to move on above-average volume Monday.

Chelsea: Northera Phase III Study Succeeds

Chelsea: Northera Phase III Study Succeeds

Chelsea's drug Northera improved symptoms for patients with a low blood pressure disorder.

Biotech Stock Mailbag: Jazz Pharma

Biotech columnist Adam Feuerstein answers readers' questions about drug and health care-related firms.

Biotech Stock Mailbag Readers' Portfolio: Update

Biotech Stock Mailbag Readers' Portfolio: Update

The BSMRP, a portfolio of biotech and drug stocks chosen by readers of my weekly Mailbag, is down 23% this year.

Chelsea Therapeutics International, Ltd. Q2 2010 Earnings Call Transcript

Chelsea Therapeutics International, Ltd. Q2 2010 Earnings Call Transcript

Chelsea Therapeutics International, Ltd. Q2 2010 Earnings Call Transcript